W STRATEGIES, LLC

Lobbying for ASTRAZENECA PHARMACEUTICALS LP · Biopharmaceutical Company.

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$80,000.00

What the client paid this registrant for the period.

Client based in

Delaware

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

Lobbying activity 1

Medicare/Medicaid

Issues around drug pricing. Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - Orphan Cures Act. Education about 340b program.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.